A large meta-analysis that included data from 56,004 individuals enrolled in GLP-1 RA CVOTs showed no association between the use of GLP-1 analogs and the risk of pancreatic cancer or acute pancreatitis [75]. The gene discussed is GLP1R; the disease is familial pancreatic carcinoma.